NDC Package 66447-0102-9 Basiliximab

Liquid - View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
66447-0102-9
Package Description:
2 kg in 1 BOTTLE
Product Code:
Non-Proprietary Name:
Basiliximab
Substance Name:
Basiliximab
Usage Information:
Basiliximab is used to prevent organ rejection in people who have received a kidney transplant. It is usually taken along with other medications (e.g., cyclosporine, corticosteroids) to allow your new organ to function normally. Basiliximab is an immunosuppressant drug known as a monoclonal antibody. It works by slowing down your body's defense system (immune system) to prevent your body from rejecting the new kidney after surgery (acute rejection).
11-Digit NDC Billing Format:
66447010209
Product Type:
Bulk Ingredient
Labeler Name:
Novartis Pharma Sas
Dosage Form:
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Active Ingredient(s):
Sample Package:
N/A
Marketing Category:
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date:
05-12-1998
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 66447-0102-9?

The NDC Packaged Code 66447-0102-9 is assigned to an UNFINISHED drug package of 2 kg in 1 bottle of Basiliximab, a bulk ingredient labeled by Novartis Pharma Sas. The product's dosage form is liquid and is administered via form.

Is NDC 66447-0102 included in the NDC Directory?

Yes, Basiliximab is an UNFINISHED PRODUCT with code 66447-0102 that is active and included in the NDC Directory. The product was first marketed by Novartis Pharma Sas on May 12, 1998 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 66447-0102-9?

The 11-digit format is 66447010209. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-166447-0102-95-4-266447-0102-09